Insider holders · CIK 0002131524
Braveheart Bio, Inc. · BRVE
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Forbion Ventures VII Management B.V.10% Owner | 11,640,546 | 10,185,478 | 21,826,024 | Aug 7, 2026 · 5:25 pm EDT | Form 4 |
| Forbion Ventures Fund VII Cooperatief U.A.10% Owner | 11,640,546 | 10,185,478 | 21,826,024 | Aug 7, 2026 · 5:25 pm EDT | Form 4 |
| Forbion Growth Opportunities Fund III Cooperatief U.A.10% Owner | 11,640,546 | 10,185,478 | 21,826,024 | Aug 7, 2026 · 5:25 pm EDT | Form 4 |
| Forbion Growth III Management B.V.10% Owner | 11,640,546 | 10,185,478 | 21,826,024 | Aug 7, 2026 · 5:25 pm EDT | Form 4 |
| Vineeta AgarwalaDirector | — | 10,232,420 | 10,232,420 | Aug 14, 2026 · 5:00 pm EDT | Form 3 |
| AH Equity Partners Bio IV, L.L.C.10% Owner | — | 10,232,420 | 10,232,420 | Aug 11, 2026 · 5:53 pm EDT | Form 4 |
| AH Bio Fund IV, L.P.10% Owner | — | 10,232,420 | 10,232,420 | Aug 11, 2026 · 5:53 pm EDT | Form 4 |
| Benjamin A Horowitz10% Owner | — | 10,232,420 | 10,232,420 | Aug 11, 2026 · 5:53 pm EDT | Form 4 |
| Marc L Andreessen10% Owner | — | 10,232,420 | 10,232,420 | Aug 11, 2026 · 5:53 pm EDT | Form 4 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner | 7,420,091 | — | 7,420,091 | Aug 10, 2026 · 10:03 am EDT | Form 4 |
| Travis MurdochCEO and President | 2,940,670 | 1,027,396 | 3,968,066 | Aug 7, 2026 · 4:30 pm EDT | Form 4 |
| Jason V ColomaDirector | — | 913,242 | 913,242 | Aug 5, 2026 · 9:07 pm EDT | Form 3 |
| David I MalekDirector | 533,845 | 239,726 | 773,571 | Aug 7, 2026 · 4:31 pm EDT | Form 4 |
| Christopher ViehbacherDirector | 609,519 | 150,338 | 759,857 | Aug 7, 2026 · 4:31 pm EDT | Form 4 |
| James Paul RickeyChief Financial Officer | 520,927 | 91,324 | 612,251 | Aug 7, 2026 · 4:41 pm EDT | Form 4 |
| Michele A. AndersonChief Development Officer | 332,161 | — | 332,161 | Aug 7, 2026 · 4:30 pm EDT | Form 4 |
| OrbiMed Capital GP IX LLCDirector | — | 273,333 | 273,333 | Aug 11, 2026 · 5:27 pm EDT | Form 4 |
| OrbiMed Genesis GP LLCDirector | — | 273,333 | 273,333 | Aug 11, 2026 · 5:27 pm EDT | Form 4 |
| Erez ChimovitsDirector | — | 273,333 | 273,333 | Aug 11, 2026 · 5:31 pm EDT | Form 4 |
| ORBIMED ADVISORS LLCDirector | — | 273,333 | 273,333 | Aug 11, 2026 · 5:27 pm EDT | Form 4 |
| David Charles LubnerDirector | 55,555 | — | 55,555 | Aug 7, 2026 · 4:30 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.